Xaparin Injection 4000 Anti-Xa IU/0.4 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) widely used as an anticoagulant for the prevention and treatment of blood clots. It works by inhibiting specific clotting factors in the blood, thereby reducing the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and other thromboembolic complications.

Xaparin is often prescribed in hospital and outpatient settings for patients at risk of developing blood clots due to surgery, prolonged immobilization, or certain medical conditions. Its predictable anticoagulant effect allows for convenient subcutaneous administration without routine laboratory monitoring in most patients.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How Xaparin Injection Works

Enoxaparin Sodium, the active ingredient, is a low molecular weight heparin that enhances the activity of antithrombin III, a natural anticoagulant in the body:

• Inhibits factor Xa, preventing the formation of blood clots

• Reduces the risk of venous thromboembolism after surgery or during prolonged immobility

• Maintains anticoagulant effect with predictable pharmacokinetics, minimizing the need for frequent monitoring

• Provides rapid onset of action after subcutaneous injection

• Helps prevent clot-related complications in high-risk patients

By targeting factor Xa, Xaparin effectively prevents the extension and formation of blood clots while maintaining a favorable safety profile compared to unfractionated heparin.

Indications

Xaparin Injection 4000 Anti-Xa IU/0.4 ml is indicated for:

• Prevention of deep vein thrombosis (DVT) in patients undergoing major orthopedic or abdominal surgery

• Treatment of DVT and pulmonary embolism (PE), with or without associated unstable angina or myocardial infarction

• Prophylaxis in medically ill patients at risk of thromboembolic events due to immobility or comorbid conditions

• Adjunct therapy in acute coronary syndrome to reduce the risk of clot formation

• Suitable for adult patients requiring short-term or long-term anticoagulation under medical supervision

Dosage and Administration

• The usual prophylactic dose is 4000 Anti-Xa IU (0.4 ml) once daily, administered subcutaneously in the abdominal area.

• Therapeutic dosing may differ depending on the patient’s weight, clinical condition, and physician guidance.

• Administer the injection deep into the subcutaneous tissue, rotating injection sites to minimize local irritation.

• Do not inject intravenously unless specifically prescribed.

• Routine coagulation monitoring is generally not required but may be recommended in special populations (e.g., renal impairment, obesity, pregnancy).

Precautions

• Use under strict medical supervision in patients with active bleeding, severe liver or kidney disease, or history of heparin-induced thrombocytopenia (HIT).

• Inform your doctor of all medications being taken to avoid interactions, especially other anticoagulants, antiplatelets, or NSAIDs.

• Pregnancy and breastfeeding use should be discussed with a healthcare professional.

• Monitor for signs of bleeding, such as unusual bruising, blood in urine or stools, or prolonged bleeding from cuts.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Mild pain, redness, or swelling at the injection site

• Minor bruising at the injection site

Serious but rare side effects may include:

• Severe bleeding, gastrointestinal or intracranial hemorrhage

• Thrombocytopenia (low platelet count)

• Allergic reactions, including rash, itching, or anaphylaxis

Seek immediate medical attention if severe bleeding, dizziness, or signs of allergic reaction occur.

Storage

Store Xaparin Injection 4000 Anti-Xa IU/0.4 ml in a cool, dry place, protected from light. Do not freeze. Keep out of reach of children.

Xaparin Injection 4000 Anti-Xa IU/0.4 ml is a reliable low molecular weight heparin for preventing and treating blood clots, reducing thromboembolic complications, and supporting safe anticoagulation therapy under medical supervision.